Innospec (IOSP) EBIT Margin (2010 - 2026)

Innospec (IOSP) has 17 years of EBIT Margin data on file, last reported at 8.05% in Q1 2026.

• For the quarter ending Q1 2026, EBIT Margin fell 159.0% year-over-year to 8.05%; the trailing twelve-month figure through Mar 2026 stood at 6.9% (down 261.0% YoY), and the FY2025 full-year result was 7.28%, down 236.0% from the prior year.
• EBIT Margin slipped to 8.05% in Q1 2026, from 10.27% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 10.28% in Q3 2024 to a low of 1.34% in Q3 2025.
• A 5-year average of 8.65% and a median of 9.12% in 2022 frame the typical range for EBIT Margin.
• Across the five-year window, EBIT Margin surged 224 bps in 2024 and plunged 895 bps in 2025, its largest moves.
• Tracing IOSP's EBIT Margin over 5 years: stood at 9.12% in 2022, then declined by 1 bps to 9.0% in 2023, then slipped by 2 bps to 8.8% in 2024, then climbed by 17 bps to 10.27% in 2025, then slipped by 22 bps to 8.05% in 2026.
• Business Quant data shows IOSP's EBIT Margin at 8.05% in Q1 2026, 10.27% in Q4 2025, and 1.34% in Q3 2025.